SG159529A1 - Vaccine - Google Patents
VaccineInfo
- Publication number
- SG159529A1 SG159529A1 SG201000826-6A SG2010008266A SG159529A1 SG 159529 A1 SG159529 A1 SG 159529A1 SG 2010008266 A SG2010008266 A SG 2010008266A SG 159529 A1 SG159529 A1 SG 159529A1
- Authority
- SG
- Singapore
- Prior art keywords
- hpv
- vaccine
- immunization
- vaccines
- virus
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000701806 Human papillomavirus Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/892—Reproductive system [uterus, ovaries, cervix, testes]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
Abstract
This invention pertains to methods and vaccines for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV 16 and HPV 18 virus like particles provides cross-protection against other HPV types.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/114,301 US20050287161A1 (en) | 2002-12-20 | 2005-04-26 | Vaccine |
PCT/EP2005/006461 WO2005123125A1 (en) | 2004-06-16 | 2005-06-14 | Vaccine against hpv16 and hpv18 and at least another hpv type selected from hpv 31, 45 or 52 |
US11/367,601 US7858098B2 (en) | 2002-12-20 | 2005-12-16 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
SG159529A1 true SG159529A1 (en) | 2010-03-30 |
Family
ID=37199195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201000826-6A SG159529A1 (en) | 2005-04-26 | 2006-04-24 | Vaccine |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1879614A2 (en) |
JP (1) | JP2008539182A (en) |
KR (1) | KR20080005583A (en) |
AR (1) | AR053715A1 (en) |
AU (1) | AU2006239471A1 (en) |
CA (1) | CA2606206A1 (en) |
EA (1) | EA013325B1 (en) |
MX (1) | MX2007013475A (en) |
NO (1) | NO20075185L (en) |
SG (1) | SG159529A1 (en) |
UY (1) | UY29499A1 (en) |
WO (1) | WO2006114273A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR201802597T4 (en) * | 2009-06-19 | 2018-03-21 | Eyegene Inc | Vaccine for cervical cancer. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9921146D0 (en) * | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
OA13147A (en) * | 2002-12-20 | 2006-12-13 | Glaxosmithkline Biolog Sa | HPV-16 and -18 L1 VLP vaccine. |
KR20070029254A (en) * | 2004-06-16 | 2007-03-13 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | Vaccine against hpv 16 and hpv 18 and at least another hpv type selected from hpv 31, 45 or 52 |
-
2006
- 2006-04-24 WO PCT/EP2006/003809 patent/WO2006114273A2/en active Application Filing
- 2006-04-24 CA CA002606206A patent/CA2606206A1/en not_active Abandoned
- 2006-04-24 JP JP2008508138A patent/JP2008539182A/en active Pending
- 2006-04-24 SG SG201000826-6A patent/SG159529A1/en unknown
- 2006-04-24 EA EA200702077A patent/EA013325B1/en unknown
- 2006-04-24 KR KR1020077027492A patent/KR20080005583A/en not_active Application Discontinuation
- 2006-04-24 MX MX2007013475A patent/MX2007013475A/en unknown
- 2006-04-24 AU AU2006239471A patent/AU2006239471A1/en not_active Abandoned
- 2006-04-24 AR ARP060101618A patent/AR053715A1/en not_active Application Discontinuation
- 2006-04-24 EP EP06753410A patent/EP1879614A2/en not_active Ceased
- 2006-04-26 UY UY29499A patent/UY29499A1/en not_active Application Discontinuation
-
2007
- 2007-10-11 NO NO20075185A patent/NO20075185L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EA013325B1 (en) | 2010-04-30 |
MX2007013475A (en) | 2008-04-02 |
JP2008539182A (en) | 2008-11-13 |
AU2006239471A1 (en) | 2006-11-02 |
EP1879614A2 (en) | 2008-01-23 |
KR20080005583A (en) | 2008-01-14 |
NO20075185L (en) | 2008-01-25 |
WO2006114273A2 (en) | 2006-11-02 |
UY29499A1 (en) | 2006-11-30 |
AR053715A1 (en) | 2007-05-16 |
EA200702077A1 (en) | 2008-04-28 |
CA2606206A1 (en) | 2006-11-02 |
WO2006114273A3 (en) | 2007-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018010586A (en) | Sting activating nanovaccine for immunotherapy. | |
MX2019003768A (en) | Hpv-specific binding molecules. | |
MX2012000035A (en) | Recombinant rsv antigens. | |
MX2011000768A (en) | Neutralizing anti-influenza a virus antibodies and uses thereof. | |
EA201070794A1 (en) | Recombinant antigens RSV | |
PH12015501637A1 (en) | Inactivated dengue virus vaccine with aluminium-free adjuvant | |
MX2011006205A (en) | Modified rsv f proteins and methods of their use. | |
WO2009009759A3 (en) | Yersinia pestis antigens, vaccine compositions, and related methods | |
WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
WO2007095320A3 (en) | Hpv antigens, vaccine compositions, and related methods | |
WO2007120673A3 (en) | Immunogenic wt-1 peptides and methods of use thereof | |
TW200740458A (en) | Vaccination against dengue virus infection | |
WO2007002470A3 (en) | Inactivated chimeric vaccines and related methods of use | |
EP1594536A4 (en) | Adjuvanted influenza vaccine | |
HK1124868A1 (en) | Truncated human papillomavirus type 16 l1 proteins | |
MA32388B1 (en) | IMMUNOMODULATION WITH IPA INHIBITORS | |
TW200731986A (en) | Use of vaccines for the treatment/prevention of the transmission of pathogens | |
WO2008134643A3 (en) | Trypanosoma antigens, vaccine compositions, and related methods | |
MY144492A (en) | Human papillomavirus vaccine comprising hpv 16 and hpv 18 virus like particles, which induce cross protection against other hpv types | |
PL1949913T3 (en) | Immunostimulatory combination for the prophylactics and treatment of hepatitis c | |
MY172788A (en) | Influenza vaccines | |
MX2007013472A (en) | Vaccine. | |
MX2007002659A (en) | Vaccine composition against hepatitis c virus. | |
WO2018066999A3 (en) | Chimeric enterovirus virus-like particles | |
SG159529A1 (en) | Vaccine |